Prescribing fewer opioid pills after surgery and providing opioid use education before surgery may reduce postoperative opioid consumption.
For patients undergoing anterior cruciate ligament reconstruction, prescribing fewer tablets is associated with lower postoperative opioid consumption.
The vast majority of orthopedic surgeons recommend prescribing a nine-day supply of around-the-clock oxycodone doses following commonly performed orthopedic surgeries.
Ocular Therapeutix has announced the launch of Dextenza for the treatment of ocular inflammation and pain following ophthalmic surgery.
Results of the study showed that compared with placebo, patients treated with IV tramadol 50mg had a statistically superior improvement in pain relief as measured by SPID24.
Intravenous administration of acetaminophen (APAP) may be less effective than oral administration of APAP for reducing opioid use after total hip or knee arthroplasty.
Investigators conducted a meta-analysis to identify predictors of poor postoperative pain control with a goal of developing personalized care pathways to improve outcomes.
Preoperative long-acting opioid use was found to be associated with longer lengths of hospital stay and increased all-cause and pain-related readmission in patients undergoing inpatient and ambulatory surgeries, respectively.
Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38% has been made available by Bausch + Lomb for the treatment of postoperative inflammation and pain following ocular surgery.
From 2013 to 2017, the rate of receiving a take-home opioid prescription remained stable after pediatric outpatient surgery as did the dose prescribed, but the maximum take-home dose declined.